Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USP IDENTITY STANDARDS FOR 23 OTC INGREDIENTS

This article was originally published in The Tan Sheet

Executive Summary

USP IDENTITY STANDARDS FOR 23 OTC INGREDIENTS may be developed with the help of industry, based on interest expressed by members of the Nonprescription Drug Manufacturers Association, NDMA said in a recent letter to FDA. NDMA noted that after surveying its members on whether they would be interested in assisting the U.S. Pharmacopeia in developing identity standards for 55 OTC ingredients that lack them, companies responded affirmatively for 22 ingredients that are currently listed in tentative final monographs and for one ingredient that is listed in a final monograph, chlorophyllin copper complex.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel